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Obesity and depression represent a growing health concern worldwide. For many years,
basic science and medicine have considered obesity as a metabolic illness, while depres-
sion was classiﬁed a psychiatric disorder. Despite accumulating evidence suggesting that
obesity and depressionmay share commonalities, the causal link between eating andmood
disorders remains to be fully understood. This etiology is highly complex, consisting of
multiple environmental and genetic risk factors that interact with each other. In this review,
we sought to summarize the preclinical and clinical evidence supporting a common etiology
for eating and mood disorders, with a particular emphasis on signaling pathways involved
in the maintenance of energy balance and mood stability, among which orexigenic and
anorexigenic neuropeptides, metabolic factors, stress responsive hormones, cytokines,
and neurotrophic factors.
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INTRODUCTION
Most of antidepressant medications have long been known to
induce weight gain, although the obesogenic mechanisms of
these treatments remain largely unknown. Most interestingly,
a large body of evidence supports the idea that non medi-
cated depressed patients with mood disorders have increased
risks of developing obesity compared to the general popula-
tion, while speciﬁc interventions aiming at reducing body weight
(including bariatric surgery and increased physical activity) have
been found to improve mood. Hence, empirical observations
have long suggested a common etiology between obesity and
depression: (1) unhealthy diets favoring energy dense foods
promote the development of both pathologies; (2) reduced phys-
ical activity and sedentary lifestyle are commonly observed in
obese and depressed patients; (3) impaired sleep and/or cir-
cadian cycles deteriorate mood and increase body weight; (4)
recurrent psychological stress and early life trauma have been
shown to contribute to a late-onset obesity and depression.
Considering the increased prevalence of obesity and depression
worldwide, a better comprehension of their common biologi-
cal bases has become crucial for identifying novel therapeutic
targets.
Indeed, obesity-related diseases, including type II diabetes,
high blood pressure, and cancer, have become one of the leading
causes of preventable death worldwide, reducing life expectancy
by 10 years or so. With depression, obesity represents a serious
public health concern that contributes to signiﬁcantly deterio-
rate the quality of life in people of most countries. Although
researches concerning obesity and depression have been con-
ducted for decades separately, recent evidence has shown that
these two pathologies might share some neurobiological under-
pinnings, and possibly a common etiology. Here, we propose to
review biological adaptations within several signaling pathways
potentially underlying the increased risks of developing both
diseases.
Obesity is a pathological condition characterized by exces-
sive body fat accumulation resulting from an imbalance between
caloric intake and expenditure. The World Health Organization
(WHO) has regularly monitored the worldwide prevalence of
overweight and obesity, and a recent estimation suggests that 11%
of the world population (more than half a billion people) is obese,
and 35% overweighed. Some monogenic forms of obesity have
been described (e.g., mutations of leptin and leptin receptor, pro-
opiomelanocortin and melanocortin-4-receptor genes) but they
are very rare and not sufﬁcient to explain the worldwide distribu-
tion of this disorder (Andreasen and Andersen, 2009). As a matter
of fact, recent clinical ﬁndings rather suggest that obesity is most
likely related to common genetic variants and/or single-nucleotide
polymorphisms, representing a genetic risk factor of vulnerabil-
ity (Frayling et al., 2007; Andreasen et al., 2008; Haupt et al., 2008;
Hunt et al., 2008).
Depression is the commonest psychiatric disorder, character-
ized by severe negative mood and inability to experience pleasure
from usually pleasurable activities (anhedonia). Depressed mood
is associated with fatigue, incapacity to concentrate, altered
appetite, sleep disorders, and metabolic complications (Ustun
et al., 2004; Kessler and Bromet, 2013). Depressive symptoms
often occur at younger age and, in the most serious cases, lead
to suicide attempts. The most recent survey conducted by WHO
in 2012 estimates that depression affects more than 350 million
people worldwide, hence constituting a major threat to public
health (Kessler and Bromet, 2013). Major depression is a het-
erogeneous disease comprising several subtypes, but the atypical
depression is one of the most diagnosed forms. Symptoms like
psychomotor retardation, insomnia, increased appetite, and body
weight gain differentiate atypical depression from the other forms
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(Gold and Chrousos, 2002). This subtype of depression is often
accompanied by visceral adiposity and shares with obesity cer-
tain metabolic, endocrine and behavioral alterations (Vogelzangs
et al., 2007; Lasserre et al., 2014). Interestingly, fat accumulation,
commonly measured by the body mass index (BMI; weight in
kilograms divided by height in squared meters, BMI), has long
been used to monitor weight gain. Increasing evidence rather sug-
gests that abdominal obesity [as referred as the waist-to-hip ratio
(WHR)], presents a stronger predictive value than total body fat
for predicting obesity-depression co-morbidity (Zhao et al., 2011;
Wiltink et al., 2013).
Like obesity, the underlying biological causes of depression
remain largely unknown, but genetic predisposition is considered
to account for ∼40% of cases (Uhl and Grow, 2004). The genetic
approach suggests that depression is a polygenic disease, deter-
mined by environmental inﬂuences in genetically predisposed
individuals (Charney and Manji, 2004). Early life stress has been
considered as one of the most critical factor triggering depres-
sion (Nemeroff and Vale, 2005). Many longitudinal studies have
shown that depression is a consistent predictor of metabolic syn-
drome since its progression is often associated with cardiovascular
diseases, diabetes, obesity, and chronic inﬂammation (Katon and
Ciechanowski, 2002). One possible explanation for this observa-
tion would take into account the fact that depressed patients often
adopt poor health behaviors, including smoking and drinking
habits (Davis et al., 2008), reduced physical activity and unhealthy
diets (Cizza, 2011).
The aim of this review is to summarize the current knowledge
about the obesity-depression relationship and discuss plausible
biologicalmechanisms underlying this association; ﬁrst by review-
ing the clinical ﬁndings supporting the intermingled interaction
between obesity and depression, second by discussing the possi-
bility that obesity may be a cause of depression and vice versa. In
particular, we will be focusing our attention on signaling path-
ways involved in the maintenance of energy balance and mood
stability, among which orexigenic and anorexigenic neuropep-
tides, metabolic factors, stress responsive hormones, cytokines,
and neurotrophic factors.
THE OBESITY-DEPRESSION ASSOCIATION AND MOST
RELEVANT MEDIATORS
Since obesity has long been considered a metabolic illness, while
depression was classiﬁed a psychiatric disorder, both basic sci-
ence and medicine have long investigated these two pathologies
separately. Most of the epidemiological and clinical investigations
conducted before the end of the 20th century provided only con-
founding outcomes, unable to prove a direct association between
obesity and depression. Nevertheless, a seminal observation pro-
posed that “socio-demographic, psychosocial and genetic factors
may render certain obese individuals more prone to depression
and vice versa” (Faith et al., 2002). The overlap between mood
disorders and obesity was later supported by an extensive study
reviewing clinical studies from 1966 to 2003 (McElroy et al., 2004).
The authors claimed that obesity and mood disorders were likely
related disorders with a distinct, but overlapping, pathophysiol-
ogy. As a consequence, only some forms of obesity and mood
disorders that share pathogenic factors would be related. Further
supporting this assumption, obesity was found to be strongly
associated with a range of common mood and anxiety disor-
ders, suggesting that social and cultural factors may represent
possible mediators and/or modulators of the obesity-depression
relationship (Simonet al.,2006).More recent publications, includ-
ing prospective cohort studies and cross-sectional researches, also
reported relevant observations supporting a bidirectional causal
link between obesity and depression, by which each disease may
contribute to the other (Markowitz et al., 2008; Luppino et al.,
2010; Faith et al., 2011). In a recent systematic review of the litera-
ture, undertaken to identify biopsychological variables associated
with the relationship between obesity and depression (Preiss et al.,
2013), physical health, decreased social activity, family depres-
sion history, childhood abuse, body image distorsion, severity of
obesity and binge eating were listed consistent risk factors for
developing comorbid obesity and depression. Collectively, these
reports suggest that speciﬁc risk factors may confer to subgroups
of obese individuals higher probability to develop depression,
and to subgroups of depressed patients greater vulnerability to
become obese. However, it is important to note that the con-
clusions drawn from of Lupino’s, Faith’s, and Preiss’s works may
be limited by quite a strong heterogeneity, in the methodology,
the patient identiﬁcation and the measures of depression and
body weight. In particular, the evidence for a mutual inﬂuence
of depression and obesity relied on reported weight and not on
objective body weight measures (Faith et al., 2011), and the nega-
tive impact of obesity on depression depended on the evaluation
of clinical depression instead of depressive symptoms (Luppino
et al., 2010).
Hence, despite limitations, current data suggest a mutual inﬂu-
ence between obesity and depression (Atlantis and Baker, 2008),
even if a few studies on adolescents would argue that depres-
sion represent a clearer risk factor for obesity (Korczak et al.,
2013), whereas obesity may not confer any higher risk for later
developing depressive symptoms (Roberts and Duong, 2013). A
reasonable conclusion would imply that obesity might represent a
risk factor for depression only under particular conditions, which
are binge eating behavior or abdominal fat deposition (Weber-
Hamann et al., 2002; Araujo et al., 2010; Zhao et al., 2011; van
Reedt Dortland et al., 2013a,b).
To summarize, the obesity-depression association seems to be
strongly dependent on several risk factors that have been clearly
established. Reduced physical activity and sedentary lifestyle have
been frequently observed in depressed (Azevedo Da Silva et al.,
2012; Song et al., 2012) and obese individuals (Bailey et al., 2007;
Tucker and Tucker, 2011). Conversely, when depressed patients
were encouraged to do physical exercise, improvement of their
mood has been repeatedly reported (Conn, 2010; Carek et al.,
2011; Rimer et al., 2012). Moreover, the efﬁcacy of exercise in
reducing risk of depression has also been observed in overweight
and obese adults (Vallance et al., 2011). Sleep disorders and cir-
cadian cycle alterations have been shown to be associated with
mood changes (Costa e Silva, 2006; Turek, 2007; Kronfeld-Schor
and Einat, 2012; Avila Moraes et al., 2013) and weight gain (Bray
and Young, 2007; Shi et al., 2013). Gender has also been con-
sidered an important factor since a stronger vulnerability in
women has been well documented for both diseases (Peveler et al.,
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2002). Unhealthy diets characterized by excessive consumption
of energy dense foods have been associated with an increased
risk of depression (Jeffery et al., 2009; Sanchez-Villegas et al., 2012;
Sanchez-Villegas and Martinez-Gonzalez, 2013) as well as obesity
(Fulton, 2010; Mozaffarian et al., 2011). In contrast, adherence to
Mediterranean diet or to others diets comprising high amounts of
vegetables and fruits have been shown to reduce risks of depres-
sion (Sanchez-Villegas et al., 2009; Jacka et al., 2010). Finally, stress
and early life trauma have been shown to signiﬁcantly contribute
to both late-onset obesity (Gustafson and Sarwer, 2004; Gunstad
et al., 2006; D’Argenio et al., 2009) and depression (Cirulli et al.,
2009).
In the next part of this article, we will be essentially focusing
on two increasing risk factors: stress and diet.
OBESITY AS A CAUSE OF DEPRESSION
The decision to eat is not only ultimately inﬂuenced by the internal
state of the caloric equation but also by non-homeostatic factors,
including food palatability and environmental cues known to trig-
ger conditioned responses (Lutter and Nestler, 2009;Williams and
Elmquist, 2012). Hence, a current consensus acknowledges that
feeding behaviors are not only inﬂuenced by caloric needs, but
also by other layers of regulation that involves the processing of
reward, notably through dopamine signaling and its ability to
pair food consumption to the context predicting its availability
(see for review, Volkow et al., 2013a). In an evolutionary per-
spective, this property of palatable foods used to be critical for
surviving in environments where food sources were scarce. Large
amounts of food were eaten when available, enabling energy to
be stored in the body (as fat) for future use (Spiegelman and
Flier, 2001). However, food habits have profoundly changed
over the past decades. Energy-dense foods, especially high fat
diets, have a reduced satiety capacity and a higher hedonic value
compared to that of meals richer in proteins and/or complex car-
bohydrates, which may explain their excessive consumption and
their role in promoting overweight and obesity (Lawton et al.,
1993; Blundell and Macdiarmid, 1997). Moreover, in modern
societies, food has become plentiful and ubiquitous. As a conse-
quence, the evolutionary adaptation inducing energy storing has
become a dangerous liability (Erlanson-Albertsson, 2005a,b) pro-
moting disinhibited and uncontrolled food seeking habits. Energy
dense foods are potentially harmful for human health not only
for their unbalance contents but also for their capacity to pro-
mote overeating behaviors (Berthoud et al., 2011; Egecioglu et al.,
2011).
Recent evidence has established that disruption of energy
homeostasis can affect the reward circuitry and that overcon-
sumption of palatable food can lead to changes in the reward
circuitry that result in compulsive food intake (Bassareo and Di
Chiara, 1999; Kenny, 2011). The peripheral signals include pep-
tides and hormones like leptin, insulin, cholecystokinin (CCK),
tumor necrosis factor- α (TNF-α) but also nutrients (sugars and
lipids), that are transported via the vagus nerve to the nucleus soli-
tary tract and directly through receptors located not only in the
hypothalamus, but also in autonomic and limbic brain regions.
These multiple signaling pathways ensure that food is consumed
when needed. However, with repeated access to highly palatable
food, some individualsmay eventually override the inhibitory pro-
cesses that signal satiety and begin to compulsively consume large
amounts of food despite nutrition overload (Zheng and Berthoud,
2007; Johnson, 2013). This loss of control and compulsive pattern
of food intake is reminiscent of the drug intake patterns seen in
addiction and has led to the description of some types of eating
disorders inducing obesity as a form of “food addiction” (Volkow
et al., 2013b).
Smith and Robbins proposed that overconsumption of palat-
able foods would lead to habit-driven responses by initiating a
devolution from goal-directed to habitual behavior. According
to this hypothesis, a process of signaling transfer would devolve
impulsively driven and hedonicallymotivated actions fromventral
to dorsal striatal control (Smith and Robbins, 2013). As a con-
sequence, the consumption of high-fat/high-sugar foods would
become less pleasurable and instead would turn into a compul-
sive response triggered by cues such as advertisements, mood,
and context. The prefrontal cortex is considered to be critical
for self-control, inhibition, and goal representation, and reduced
activity in this region is associated with higher levels of impul-
sivity and compulsivity. Since executive function difﬁculties have
been reported in overweight and obese individuals, and a decrease
in orbito-frontal cortex volume correlated with disinhibited eat-
ing in obese adolescents, the shift from ventral to dorsal striatal
control described above may also be associated with impair-
ments in executive functions such as cognitive control, ﬂexibility,
decision-making, and working memory. Ultimately, individuals
who experience a lack of control in the face of food persistently
overuse their preferred food despite severe health, social, legal, and
ﬁnancial problems; and are unsuccessful at attempting to cut back
or reduce their consumption. These behaviors are typically accom-
panied by feelings of guilt, remorse, sometimes triggering excessive
food restriction and distress that in turn, promote palatable food
intake to alleviate these dysphoric signs, further accentuating the
spiraling distress (Fulton, 2010).
In other words, negative mood, provoked by palatable food
withdrawal or by the incapacity to lose weight, often results in
the adoption of an abnormal eating behavior characterized by
recurrent cycles of dieting and overeating (Polivy and Herman,
1985; Petroni et al., 2007; Stice et al., 2008). Consequently, overeat-
ing episodes may turn into an overt binge-eating disorder (BED)
that is frequently associated with a feeling of distress. Consis-
tent with this, obese patients suffering from BED often present
severe depressive symptoms (Heatherton and Baumeister, 1991;
Stice et al., 2000; Spoor et al., 2006; Araujo et al., 2010; Blumenthal
and Gold, 2010; Faulconbridge and Bechtel, 2014). These clinical
ﬁndings are largely supported by experiments inwhich compulsive
overeating has been induced in laboratory animals. For example,
the capacity of palatable foods, when taken in a discontinuous
pattern, to promote binge eating behavior has been repeatedly
demonstrated in rodents (Colantuoni et al., 2002; Bello et al., 2003;
Cottone et al., 2008; Corwin et al., 2011). Interestingly, several of
these works have also proved that long-term intermittent access to
palatable food is accompanied by depressive-like phenotypes and
metabolic alterations (Cottone et al., 2009b; Rossetti et al., 2013).
Traumatic stress experiences, especially in early life, are known
to affect mood and feeding behavior and therefore, they constitute
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a strong element conferring higher vulnerability for developing
obesity and depression. Compelling evidence suggests that stress
increases palatable food preference and consumption both in
humans (Gluck et al., 2004; Gluck, 2006; Adam and Epel, 2007;
O’Connor et al., 2008; Tryon et al., 2013a,b) and in rodents (Fos-
ter et al., 2006; Moles et al., 2006; Machado et al., 2013; Patterson
and Abizaid, 2013). A likely explanation for such stress-induced
preference is that palatable food acting as a “comfort food”would
be able to alleviate discomfort (Jeffery et al., 2009). In agreement
with this hypothesis, a large body of preclinical studies has demon-
strated that, not only chronic stress promotes palatable food intake
(Dallman et al., 2003; Pecoraro et al., 2004) but its withdrawal
increases stress sensitivity and depressive-like behaviors (Avena
et al., 2008; Teegarden and Bale, 2008; Iemolo et al., 2012).
Industrial foods that progressively replace healthier fresh
cooked meals worldwide are harmful for human health not only
for their strong rewarding properties but also for their low con-
tent of poly-unsatured fatty acids (PUFAs). Accordingly, higher
intake of saturated fatty acids has been found to promote vis-
ceral fat deposition and mood alterations (Schulze et al., 2006;
Akbaraly et al., 2009; Molenaar et al., 2009; Jacka et al., 2010).
Diets containing low levels of PUFA also increase the risk of
depression (Appleton et al., 2010), while lower levels of omega-
3 PUFA have been recently reported in the blood of depressed
patients (Ross et al., 2007; Lin et al., 2010). Similar conclusions
about the role of PUFA in depression have been indirectly drawn
from people adhering to a Mediterranean diet. This diet, priv-
ileging vegetables, fruits and ﬁsh and containing high levels of
PUFA, has been shown to limit excessive weight gain and obe-
sity (Schroder et al., 2004, 2007; Romaguera et al., 2009) as well
as depression (Sanchez-Villegas et al., 2009). Beside these human
studies, the relevance of PUFA in the prevention of depres-
sions has also been reported in rodents (Fedorova and Salem,
2006; Huang et al., 2008) and non human primates (Chilton et al.,
2011).
In sum, protracted consumption of unhealthy diets and recur-
rent stress could interfere with the homeostatic control of the
energetic balance and modify the reactivity of the rewarding sys-
tem leading ultimately to a loss of control over food intake. The
resulting compulsive overeating might trigger a BED and eventu-
ally lead to abdominal fat deposition, two factors tightly associated
with depression (Weber-Hamann et al., 2002; Rivenes et al., 2009;
Zhao et al., 2011; van Reedt Dortland et al., 2013a,b).
LEPTIN SIGNALING
Leptin is a peptide hormone belonging to the adipokines family
that is secreted primarily from adipocytes of the white adipose tis-
sue. Leptin serum levels change depending on the feeding/fasting
state and correlate with body mass (Seeley andWoods, 2003). This
peptide is coded by the obese gene ob and exerts its physiologi-
cal function mainly in the brain. After release in the bloodstream,
leptin pass across the blood–brain barrier (BBB) using a receptor-
mediated transport (Banks et al., 1996). LepRb is the long form
of the leptin receptor and is critical for leptin signaling cascade
(Banks et al., 2000). LepRb was ﬁrst identiﬁed in the hypotha-
lamus and its activation was related to the anorectic effect of
leptin, that is its ability to reduce food intake and increase energy
expenditure (Chehab, 2000). Later, the presence of this receptor
in other brain structures, namely the hippocampus, prefrontal
cortex, ventral tegmental area (VTA) and amygdala has sug-
gested additional roles of leptin in other physiological functions,
amongwhich learning andmemory (Farr et al., 2006; Harvey et al.,
2006),motivation for reward (Farooqi et al., 2007; Grosshans et al.,
2012), and mood regulation (Guo et al., 2013; Milaneschi et al.,
2014).
The role of leptin in the orchestration of food intake and energy
expenditure in the hypothalamus has been largely described in
the literature (Cone, 2005; Coll et al., 2007). Brieﬂy, leptin is
released by the adipose tissue, crosses the BBB and reaches the
arcuate nucleus (ARC) of the hypothalamus where interacts with
its receptors localized on two neuron populations: the orexi-
genic neuropeptide Y (NPY)/agouti related peptide (AgRP) neu-
rons and the anorexigenic proopiomelanocortin (POMC)/cocaine
and amphetamine regulated transcript (CART) neurons. Leptin
inhibits the former and activates the latter, leading to a sati-
ety signal (Spiegelman and Flier, 2001). It has long been known
that impairment in leptin signaling causes obesity, increased food
intake and fat deposition (Pelleymounter et al., 1995a; Speakman
et al., 2007). These observations gave rise to the hypothesis that
leptin could be used as anti-obesity treatment, but clinical inves-
tigations have shown that obese patients have chronically high
levels of circulating leptin (Lu et al., 2006). This apparent contra-
diction suggests the emergence of a leptin resistance syndrome,
a phenomenon also observed with insulin in diabetic patients.
The precise mechanism responsible for leptin resistance is not yet
known but may be linked to down-regulation of leptin receptors,
reduced transport of leptin across the BBB or altered intracellular
transduction of leptin signaling (Jung and Kim, 2013).
Abnormalities in leptin functioning are also believed to enhance
the motivation for palatable food and promote its overconsump-
tion. This assumption comes from the discovery that leptin
receptors are also localized in brain reward structures (Figlewicz
and Benoit, 2009). In particularly, leptin receptors have been
detected in dopaminergic neurons of the VTA and electrophys-
iological studies in rodents have established that leptin decreases
the ﬁring rate of these neurons reducing dopamine release and
food intake (Hommel et al., 2006). There is also evidence that lep-
tin is able to regulate the incentive salience of reward because
food restriction in rodents (that corresponds to a reduction
of leptin signal) increases the preference for sucrose and other
drugs in a conditioned place-preference paradigm (Figlewicz and
Benoit, 2009). In other words, leptin impairment may result in
a higher stimulation of dopaminergic neurons that, in turn, may
increase the incentive for palatable food and ultimately its con-
sumption. In support of this hypothesis, some animal studies
demonstrated that injection of leptin in the VTA reduced food
intake whereas a viral-mediated knockdown of leptin receptor
in the same brain structure had opposite effect (Hommel et al.,
2006).
In the last years, the scientiﬁc interest for leptin has also been
extended to psychiatric disorders, such as anxiety and depression.
Mutant mice that lack leptin signaling have been found to develop
depressive symptoms (Collin et al., 2000; Sharma et al., 2010;
Yamada et al., 2011) whereas systemic and central administration
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of leptin in wild-type mice reduced anxiety and depressive-like
behaviors (Asakawa et al., 2003; Lu et al., 2006; Finger et al., 2010;
Liu et al., 2010; Yamada et al., 2011; Guo et al., 2013). In addition,
other preclinical studies have shown that circulating leptin lev-
els are modulated by stress since chronic unpredictable stress or
chronic social defeat, but not acute stress, decreased basal levels of
leptin in rats (Lu et al., 2006; Ge et al., 2013).
Although these ﬁndings seem to support a reduction of leptin
levels in animal models of depression, the current knowledge on
the role of leptin signaling in human depression remains unclear.
Leptin levels in depressed patients have been reported to be lower,
higher or equal to those observed in control patients (Deuschle
et al., 1996; Antonijevic et al., 1998; Rubin et al., 2002; Esel et al.,
2005; Zeman et al., 2009). However, studies with larger size sam-
ples reported a negative correlation between plasma leptin levels
and major depression, hence supporting the idea that decreased
leptin signaling may be a shared biological alteration in both obe-
sity anddepression (Kraus et al.,2001;Atmaca et al.,2002;Westling
et al., 2004; Jow et al., 2006; Lawson et al., 2012). In conclusion,
there is a current consensus suggesting a reduced leptin signal-
ing in human depression, even though, this association might be
stronger in certain subtype of depression ormight be inﬂuenced by
different factors including age, sex, body mass, and co-morbidity
with other disorders (Gecici et al., 2005).
Nevertheless, the involvement of the leptin hormone in the
emergence of depressive symptoms remains unclear. In this
regards, some ﬁndings suggest that leptin may exert an antide-
pressant effect by modulating the hypothalamic-pituitary-adrenal
(HPA) axis function. An early in vitro study on primary cultures
of bovine adrenocortical cells demonstrated the capacity of leptin
to reduce the transcription of cortisol (Bornstein and Chrousos,
1999). Mutant mice with altered leptin signaling exhibit hypercor-
ticosteronemia,whereas leptin replacement reduces corticosterone
levels in these mice (Chen et al., 1996; Chua et al., 1996; Arvan-
iti et al., 2001). Similarly, an inverse correlation between basal
levels of leptin and release of glucocorticoids (GCs) has been
found in humans (Licinio, 1998; Komorowski et al., 2000). Beside
a direct effect on GCs, it has also been speculated that leptin may
limit the activity of the HPA axis by suppressing the hypothala-
mic corticotropin-release factor (CRF) release (Ahima et al., 1996;
Huang et al., 1998; Arvaniti et al., 2001).
A second hypothesis in favor of the antidepressant role of
leptin is linked to the neurotrophic hypothesis of depression,
since this adipokine may facilitate neurogenesis. In particular,
mutant mice exhibiting an altered leptin signaling present reduced
brain volume and abnormal expression of neuronal and glial
proteins. These morphological changes have been attributed to
the lack of leptin, since leptin administration was shown to
normalize the brain morphology (Vannucci et al., 1997; Ahima
et al., 1999; Steppan and Swick, 1999). Consistent with a neu-
rotrophic role of leptin, it has been shown that this hormone
facilitated the formation of speciﬁc neuronal projection path-
ways inside the hippocampus (Bouret et al., 2004). It also has
been shown that leptin increased the motility and density of
dendritic ﬁlopodia, and enhanced the number of hippocampal
synapses (O’Malley et al., 2007). Further, convergent evidence
demonstrated the importance in the hippocampus: ﬁrst, mice
with a selectively ablation of Lep-Rb in glutamatergic hippocam-
pal neurons showed long-term potentiation (LTP) impairment,
anhedonia-like phenotype, behavioral despair and enhanced social
avoidance, and second, speciﬁc reduction of leptin receptors in
the dentate gyrus, where neurogenesis is considered critical, was
shown to induce marked depressive-like behavior (Guo et al.,
2013).
In summary, accumulating ﬁndings established multiple and
complex implications of leptin signaling in physiological and
cognitive functions that extend energy balance regulation, and
a compromised leptin signaling represents a serious candidate
contributing to the development of pathological adaptations
underlying the overlap between obesity and depression.
INFLAMMATION AND CYTOKINES RELEASE
Obesity is associated with a low-grade chronic systemic inﬂamma-
tion and inparticularly interleukin-6 (IL-6), TNF-α andC-reactive
protein (CRP) are present at high levels in the serum of obese peo-
ple (Shelton and Miller, 2010; Gregor and Hotamisligil, 2011).
Very recent epidemiological studies reported that increased levels
of CRP correlated with depressive symptoms and abdominal obe-
sity (Alvarez et al., 2013; Daly, 2013; Wium-Andersen et al., 2013)
and other clinical works have found CRP to be the most consistent
marker of the obesity-depression association (van Reedt Dortland
et al., 2013a,b).
Two factors are responsible for chronic increase of circulat-
ing cytokines in obese patients. The ﬁrst is fat deposition. Fat
is stored in the adipocytes of the white adipose tissue and an
increased adiposity, especially around the abdomen, stimulate
these cells to release inﬂammatory factors, including adipokines,
cytokines, and chemokines (Shelton and Miller, 2010; Gregor and
Hotamisligil, 2011). Macrophages attracted into the adipose tissue
by chemokinesmassively produce inﬂammatory factors, leading to
the systemic inﬂammation observed in human obesity (Clement
et al., 1997; Wellen and Hotamisligil, 2003). The second factor is
diet quality. In a study conducted on a sample of healthy Greek
population, the consumption of several food items was scored
during a year. Higher scores, reﬂecting a stronger adherence to the
Mediterranean diet, were inversely associated with biomarkers of
systemic inﬂammation (Chrysohoou et al., 2004). The protective
effect of the Mediterranean diet was more recently conﬁrmed by
other studies revealing that lower plasma concentration of CRP,
IL-6, TNF-α were closely related to this type of diet (Camargo
et al., 2012; Rimer et al., 2012; Urpi-Sarda et al., 2012). To date,
the identiﬁcation of the Mediterranean diet nutrients supposed to
alleviate signs of chronic inﬂammation remain unclear. A recent
study reviewed 26 randomized clinical trials and established that
ω-3 PUFA was of particular interest to lower inﬂammatory mark-
ers (Bloch andHannestad, 2012; Kiecolt-Glaser et al., 2012; Calder,
2013).
Cytokines are mostly produced in peripheral tissues and due
to their large molecular weight cannot freely pass cellular mem-
branes, but they can enter the brain through the leaky regions of
the BBB or via cytokine-speciﬁc transporters. Cytokine signal also
arrives inside the brain by afferent nerve ﬁbers (the vagus nerve
for example) or inﬁltration in the brain parenchyma of periph-
erally activated monocytes (Plotkin et al., 1996; Rivest et al., 2000;
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Quan and Banks, 2007; D’Mello et al., 2009). Evidence for ele-
vated levels of neuroinﬂammatory cytokines has been found in
the hypothalamus of rodents after 4 weeks of high-fat feeding, and
in postmortembrain samples of obese patients aswell (Thaler et al.,
2012). Noteworthy, whether it is diet-induced or genetically pro-
grammed, animal models of obesity present severe inﬂammation
of hypothalamus (Velloso et al., 2008; Wisse and Schwartz, 2009).
As a consequence, hypothalamic neurons are injured and the activ-
ity of some neurotransmitters, NPY and POMC, compromised
(Thaler and Schwartz, 2010; Thaler et al., 2010). Hence, it is likely
that excessive amounts of cytokines may exaggerate hypothalamic
neuroinﬂammation and consequently, alter food intake regulation
and energy expenditure, worsening signs of obesity in a spiraling
down mechanism.
Concomitantly, the neuroinﬂammation response may exac-
erbate signs of depression as well, since chronic increase in
pro-inﬂammatory and inﬂammatory markers has been repeti-
tively observed in depressed patients. It is important to note
that inﬂammation is a protective mechanism for the body to
ﬁght microbial and viral attacks. The short-term release of pro-
inﬂammatory cytokines in the blood, including interleukin-1α
(IL-1α), interleukin-1β (IL-1β), TNF-α, and IL-6, triggers fatigue,
psychomotor retardation, sleep alteration and anhedonia. The
“sickness behavior” is supposed to save energy, minimize risks
and promote recovery. However, similitudes with the depressive
symptoms are quite striking and suggest that depression could be
associated with a long-term activity of cytokines (Maes et al., 1995;
Charlton, 2000).
In other words, the“cytokine hypothesis of depression”consid-
ers depression as the result of a maladaptive response that occurs
after a sustained and persistent cytokine release (Dantzer et al.,
2008). In favor of this theory,many recent clinical data have shown
elevated concentrations of inﬂammatorymarkers (includingTNF-
α, IL-6, IL1-β, and CRP) in the blood and in the cerebral spinal
ﬂuid of patient with major depression (Kim et al., 2007; Simon
et al., 2008; Howren et al., 2009; Dowlati et al., 2010).
It is also important to note that psychiatric disorders, among
which depression, have frequently been described in patient
afﬂicted by pathologies associated with chronic inﬂammation;
it is particularly true for rheumatoid arthritis and autoimmune
disorders. Systemic lupus erythmatosus for instance is frequently
associated with episodes of major depression. And further, ele-
vated IL-6 spinal ﬂuid levels found in these patients often
correlate with the severity of their neuropsychiatric symptoms
(Fragoso-Loyo et al., 2007).
The assumption that inﬂammatory processes may take part in
the etiology of depression is also supported by the observation
of patients receiving cytokine treatments (e.g., interferon-α) as
an anti-cancer or anti-viral therapy. Despite the clinical efﬁcacy
of such therapy, more than 45% of treated subjects developed a
major depression (Capuron and Miller, 2004; Raison et al., 2006).
Moreover, with regards to antidepressant therapies, it has also been
noted that their efﬁcacy was related to a reduction of plasmatic
levels of inﬂammatory markers (Lanquillon et al., 2000; O’Brien
et al., 2007; Hannestad et al., 2011).
Meanwhile, preclinical ﬁndings have demonstrated that mice
with targeted deletions of the gene coding for IL-6 or for
TNF-α receptor show depressive-resistant phenotypes (Chour-
baji et al., 2006; Simen et al., 2006). In other genetically and
pharmacologically induced inﬂammation models, the presence
of depressive-like behaviors has been demonstrated in several
paradigms including the tail suspension and forced swim tests,
as well as in protocols based on social interaction monitoring
(Anisman et al., 2005; Moreau et al., 2008; Sukoff Rizzo et al.,
2012). Collectively, these ﬁndings suggest that depression may
represent a maladaptive response to a sustained cytokines release,
which may occur in predisposed subjects when the activation of
the immune system is heightened in intensity or duration.
While the plasmatic increase of cytokines in depression is
conﬁrmed by several studies, little is known about how these
modulators of the immune response may affect mood regula-
tion. Recently, it has been proposed that chronic inﬂammation
can affect central neurotransmission, in particular, those of the
serotonergic and dopaminergic systems. Particular interest has
been accorded to the interaction between cytokines and serotonin
because of the serotonergic hypothesis of depression (Coppen and
Wood, 1978; Blokland et al., 2002; Wichers and Maes, 2004).
Brieﬂy, cytokines seem to interfere with the serotonin sys-
tem at different levels: synthesis, release and synaptic reuptake
(Dunn and Wang, 1995; Dunn et al., 1999; Anisman et al., 2005).
The amount of serotonin in the brain is highly dependent on
the availability of the amino acid tryptophan and its trans-
formation in 5-hydroxytryptophan by the enzyme tryptophan
hydroxylase (TH; Delgado et al., 1990). Tryptophan levels also
depend on an alternative metabolic pathway via its conversion
in kynurenine upon the activation of the enzyme indoleamine
2,3-dioxygenase (IDO) localized in multiple cell types includ-
ing macrophages, astrocytes, and microglia. Hyperactivation of
this pathway leads to a depletion of tryptophan and ultimately,
decreases the brain amounts of serotonin (Schwarcz and Pel-
licciari, 2002; Schrocksnadel et al., 2006). Intriguingly, several
cytokines (e.g., TNF-α, interferon-α and interferon-γ) and their
signaling pathways have been found to activate IDO, hence lim-
iting tryptophan availability (Takikawa et al., 1999; Popov et al.,
2006). Consistent with these in vitro observations, high plas-
matic levels of pro-inﬂammatory cytokines have been associated
with IDO induction in mice displaying depressive-like pheno-
types (O’Connor et al., 2009a,b). In line with this interpretation,
it also has been shown that: (1) IL-1, IL-6, and TNF-α are able
to reduce brain levels of serotonin by accelerating its catabolism
(Clement et al., 1997; Dunn, 2006) and (2) cytokines may facil-
itate serotonin synaptic reuptake (Blakely and Berson, 1992;
Bull et al., 2009; Lotrich et al., 2009) hence reducing serotonin
neurotransmission.
In parallel, chronic inﬂammation was shown to alter dopamine
neurotransmission as well. Symptoms of depression have been
shown to correlatewith a reduced prefrontal and striatal dopamine
activity (Dunlop and Nemeroff, 2007) and repeated interferon-α
administration has been shown to decrease dopaminergic neural
activity in the mouse brain (Shuto et al., 1997). Cytokines may
also interfere with the dopamine transporter, or affect dopamine
synthesis by inhibiting tetrahydrobiopterin (BH4), an important
co-factor for tyrosine hydroxylase enzyme that converts tyrosine
into L-DOPA (Kitagami et al., 2003). Finally, cytokines also affect
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the HPA axis functioning. Hyperactivity of the HPA axis is a
hallmark of depression (see next section) and several observa-
tions have demonstrated that cytokines and cytokine-inducers
can potently activate the stress cascade. Administered acutely,
cytokines have been shown to increase the expression and the
release of CRF, adrenocorticotropic hormone (ACTH), and corti-
sol (Besedovsky and del Rey, 1996; Pariante and Miller, 2001; Pace
and Miller, 2009).
Even though these ﬁndings linking cytokines to depression have
to be conﬁrmed, the idea that neuroinﬂammation might be a
leading cause of depression, represents a fascinating prospective
connecting mood to eating disorders.
DEPRESSION AS A CAUSE OF OBESITY
The hyperactivation of the HPA axis and reduced neurogenesis
and/or brain plasticity are two current hypotheses trying to rec-
oncile the past and recent assumptions about the pathogenesis
of depression. Interestingly, these biological processes have been
demonstrated to participate to the etiology of obesity as well, and
thus may represent a thread union between these two pathologies
(Sinha and Jastreboff, 2013; Sominsky and Spencer, 2014).
HYPERACTIVATION OF THE HPA AXIS
A large body of clinical and preclinical evidence has led to the
general consensus that hyperactivation of the HPA axis follow-
ing a chronic stress experience is a leading cause of depression.
Animal and human survival depends on the capacity to recog-
nize and face harmful stimuli (Chrousos, 2009). In this context,
stress response allows to react to potentially harmful threat and
to maintain body homeostasis through transient physiological
and behavioral adaptations (Chrousos and Gold, 1992; McEwen,
1998). This temporary adaptive stress response is directed to
increase energy availability in those organs of the body involved
to counteract the stressor. As a consequence, cardiac output and
respiration are accelerated, catabolism is increased and blood
ﬂow is potentiated in the brain and muscles (Gilbey and Spyer,
1993).
These adaptive responses rely on the activation of the auto-
nomic nervous system and the HPA axis, a complex neuro-
endocrine system composed of multiple brain structures and
peripheral organs (Tsigos and Chrousos, 2002). Emotional and
stressful stimuli, processed in the amygdala, activate the paraven-
tricular nucleus of the hypothalamus (PVN) and trigger a cascade
of physiological adaptations through the release of corticotropin-
releasing hormone/factor (CRH/CRF; de Kloet, 2000; Charman-
dari et al., 2005). CRF target neurons are located in the anterior
pituitary gland and release the ACTH in the bloodstream. This
hormone stimulates the cortex of the adrenal gland to secrete GCs,
cortisol in humans, and corticosterone in rodents. GCs receptors
are widely distributed in the body and their binding with GCs
leads to the activation or repression of a plethora of genes (Bam-
berger et al., 1996; Dostert and Heinzel, 2004), among which those
coding for enzymes involved in promoting the hepatic synthesis of
glucose from non-glucidic substrates (i.e., lactate, pyruvate, and
amino acids). GCs also contribute to increase blood glucose lev-
els, and antagonize the anabolic activities of insulin, growth, and
thyroid hormones (Rizza et al., 1982).
When the exposure to stressful stimuli is limited, the stress
response has short duration because GCs exert a feedback inhi-
bition on the HPA axis. Speciﬁcally, they act on the pituitary
and hypothalamus limiting the release of CRF and ACTH, which
reduces their own activity. GCs also stimulate GC receptors in the
hippocampus, where inhibitory GABAergic projections to PVN
neurons block the CRF release (Boudaba et al., 1996; Herman
et al., 2002). Higher cortical structures, including the dorsome-
dial prefrontal cortex and the prelimbic cortex, also control the
stress response (Diorio et al., 1993; Radley et al., 2008).
During the past three decades, several groups reported com-
pelling evidence showing that prolonged stress response (in
particular sustained CRF and GCs release) may represent a bio-
logical mechanism triggering depression (Carroll, 1982; Holsboer,
2000; Pariante, 2003; Strohle and Holsboer, 2003) and obesity
(Bjorntorp and Rosmond, 2000; Pasquali and Vicennati, 2000),
even though psychosocial stress would exert only a modest effect
on weight gain (Wardle et al., 2011). CRF has been particularly
studied and its role in the emergence of depressive symptoms
has been well documented (Grigoriadis, 2005). The activity of
CRF depends on its binding on two types of receptors, both
widely express in the brain and body, called CRF-R1 and CRF-
R2. Three other endogenous ligands with different afﬁnity for
CRF receptors have been revealed and named urocortin1 (UCN1),
UCN2, and UCN3 (Nakayama et al., 2011). Consistent with the
CRF hypothesis of depression, some studies have shown that
depressive patients exhibit high levels of CRF in the cerebrospinal
ﬂuid (Nemeroff et al., 1984), increased number of CRF express-
ing neurons in the PVN, elevated expression of CRF mRNA in
the same neurons and reduced CRF receptor density (Banki et al.,
1987; Raadsheer et al., 1994; Merali et al., 2004). Early observa-
tions in rodents also found that intracerebroventricular (ICV)
administrationof CRF induced anxiety anddepression-like behav-
iors, whereas the injection of CRF antagonists produced the
opposite effect, conﬁrming the potential antidepressive proper-
ties of CRF ligands (Deak et al., 1999; Zobel et al., 2000; Seymour
et al., 2003). Beside pharmacological data, genetic manipulations
in rodents conﬁrmed these observations: overexpression of the
CRF gene in mice led to increased anxiety-like behaviors and
impaired stress (Stenzel-Poore et al., 1994). Interestingly, these
behavioral changes were accompanied by enhanced food intake,
weight gain and insulin (Coste et al., 2001). However, whereas
transgenic mice lacking CRF-R1 showed a reduced stress response
and blunted anxiety-like behaviors (Smith et al., 1998; Timpl et al.,
1998), those lacking CRF-R2 exhibited pronounced anxiety-like
behaviors and stress hypersensitivity (Bale et al., 2000; Coste et al.,
2000).
Compared to depression, less is known about a direct role of
CRF signaling on obesity. The involvement of the CRF family
peptides (CRF, UCN1, UCN2, and UCN3) in energy balance and
food intake regulation has been documented (Chalew et al., 1995;
Richard et al., 2002), but most of the data are rather contradic-
tory (Levine et al., 1983; Negri et al., 1985; Asakawa et al., 1999;
Ushikai et al., 2011). Similarly to what is observed with anxio-
depressive like behaviors, the impact of the CRF system on energy
balance largely depends on CRF ligands, the type of receptor and
the brain structure targeted. Indeed, recent observations reported
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that blocking CRF-R1 signaling in the central nucleus of the amyg-
dala prevented palatable food intake and anxiety-like behaviors in
the rat (Cottone et al., 2009a; Iemolo et al., 2013). Meanwhile,
CRF-R2 activation with UCN2 was shown to reduce high-fat food
consumption when injected ICV in the rat, conﬁrming a former
observation in mice lacking CRF-R2, which consume larger meals
compared to wild type mice (Bale and Vale, 2003; Tabarin et al.,
2007).
Further conﬁrming a role of the HPA axis dysfunction in
the emergence of excessive food intake and obesity, it has been
recently demonstrated in humans that the systemic administra-
tion of a low dose of CRF stimulated food intake, likely through
GCs release (George et al., 2010). The Cushing’s syndrome, a
disease resulting from pituitary/adrenal tumors or chronic treat-
ment with corticosteroids, also represents a coincident model
of depression and obesity (Sonino et al., 1998). Clinical obser-
vations of these patients revealed that cortisol hypersecretion
is accompanied by visceral adiposity, metabolic syndrome and
mood related disorders. In order to explain this, early and more
recent researches have pointed out that the excessive release of
GCs impairs the ability of insulin to promote glucose uptake,
induces metabolic syndrome and promotes body fat deposition
(Brindley and Rolland, 1989; Black, 2006). Likewise, chronically
elevated GCs contribute to visceral fat accumulation in primates
(Shively, 1998; Shively et al., 2009) and humans (Marin et al., 1992;
Rosmond et al., 1998; Epel et al., 2000; Spencer and Tilbrook,
2011). Finally, the diurnal variations of circulating cortisol levels
positively correlated with the hip-to-waist ratio in obese patients
(Weaver et al., 1993; Lasikiewicz et al., 2008). Beside insulin and
leptin resistance (Zakrzewska et al., 1997, 1999; Jéquier, 2002a,b),
GCs may alter the energetic balance and stimulate food intake
acting on different brain structures. GCs receptors are widely
distributed in hypothalamic nuclei implicated in energy home-
ostasis such as ARC, LH, and PVN (Morimoto et al., 1996) and
long-lasting stimulation of GC receptors in these brain regions is
known to potentiate orexigenic signals modulating the expression
of genes involved in energy balance. In particular, the expression
of one gene contributing to satiety signaling, the POMC gene, has
been found to be reduced following GC receptor stimulation and
increased after adrenalectomy (Cavagnini et al., 2000; Savontaus
et al., 2002).
While clinical data strongly support that chronically elevated
GCs receptors affect the hedonic regulation of food intake and
increase the preference for palatable food, which most likely con-
tributes to excessive fat deposition (Dallman et al., 2003, 2006;
Pecoraro et al., 2004; Germano et al., 2007), enhanced levels of
corticosterone have been found in different animal models of obe-
sity including fa/fa rats, db/db, and ob/ob mice (Guillaume-Gentil
et al., 1990). Conversely, the absence of GCs, due to adrenalectomy,
provoked body weight loss and food intake reduction in rodents,
effects that could be reversed by corticosterone administration
(Saito and Bray, 1984; Pralong et al., 1993; Makimura et al., 2000).
Accumulating evidence suggests that diet composition may also
play a role in modulating the HPA axis functions. Although, only
a few studies have covered this topic, some of them indicate that
unbalanced fat diets may perturb lipid metabolism and, as a con-
sequence, increase circulating levels of GCs. Consistent with this
hypothesis, a recent study on woman health has reported a posi-
tive correlation between consumption of saturated fatty acids and
diurnal variation of cortisol (Garcia-Prieto et al., 2007). In addi-
tion, converging evidence has found that patients who received
diets supplemented with PUFA or ﬁsh oil had reduced ACTH and
cortisol rise after acute stress (Delarue et al., 2003; Michaeli et al.,
2007).
Collectively, these observations emphasizes that stress alters
the HPA axis homeostasis and most likely triggers the onset and
worsening of depression. Since the hypothalamus is themain brain
orchestrator regulating energy balance and food behavior, it is not
surprising that alterations in the HPA axis may lead to overeating
and obesity.
NEUROGENESIS AND THE BRAIN-DERIVED NEUROTROPHIC FACTOR
(BDNF)
The monoaminergic hypothesis of depression has long proposed
that depression originates from decreased monoamine neuro-
transmission. Despite the impressive number of pre-clinical and
clinical studies that have been conducted over the last 40 years,
the validity of this theory remains debatable (Mulinari, 2012;
Blier and El Mansari, 2013). In particularly, the discrepancy
between the rapid increase of monoamine signaling occurring
upon antidepressant treatment and their delayed therapeutic
effect remains unclear. Moreover, inconsistent clinical ﬁndings
have failed to demonstrate a decrease in monoamine basal lev-
els in depressed patients compared with health people. Thus,
the altered monoamine neurotransmission classically reported
in depression is now considered to reﬂect the consequences of
neuronal damage. Historically neurons have been presumed to
not regenerate. However, recent evidence demonstrated that the
mammalian central nervous system retains the capacity to pro-
duce new neurons that can integrate neural network (Ming and
Song, 2011). Two brain regions have been extensively studied: the
subventricular zone of the lateral ventricles and the subgranular
region of the dentate gyrus in the hippocampus (Duman et al.,
2001; Duman, 2002; Kempermann and Kronenberg, 2003). Hip-
pocampal neurogenesis, which is pivotal for cognitive functions
and mood control, is strongly affected by chronic stress which
causes shortening and pruning of neuron dendrites and reduc-
tion of the ﬁnal number of newborn neurons (McEwen, 1999;
Duman, 2004a,b). Accordingly, morphologic and morphometric
studies of brains of depressed patients have found a reduction of
hippocampal volume due, at least in part, to an impaired neu-
rogenesis (Sheline, 1996; Bremner et al., 2000; Sheline et al., 2003;
Stockmeier et al., 2004; Lucassen et al., 2010). Interestingly, antide-
pressant treatments have shown to reverse neural atrophy, cell
loss and stimulate neurogenesis (Duman and Monteggia, 2006).
Similar observations have been reported with preclinical inves-
tigations, conﬁrming that unpredictable chronic stress protocols
suppressed hippocampal neurogenesis in rodents (Watanabe et al.,
1992; Malberg and Duman, 2003; Pham et al., 2003; Mineur et al.,
2007).
Neurotrophins constitute an important class of signaling
molecules in the brain, playing a pivotal role in brain develop-
ment, neuron survival and synaptic plasticity. The brain-derived
neurotrophic factor (BDNF) has received particular attention,
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since it is considered a relevant biomarker of depression and
suicidal behavior, and a possible downstream target of a vari-
ety of antidepressant drugs (Dwivedi, 2009; Lee and Kim, 2010).
Hippocampal neurogenesis is an important process that appears
to be involved in maintaining balanced mood. A large body
of evidence identiﬁes BDNF, and its TrkB receptor, as two key
elements in the orchestration of different phases of neuroge-
nesis such as cell proliferation, migration, differentiation and
death. The rationale for the involvement of BDNF in depres-
sion comes from the observation that stress can down-regulate
the expression of this neurotrophic factor in brain structures
known to control emotions (Dwivedi, 2009; Lee and Kim, 2010).
Stress-related disorders, among which major depression, is con-
sidered to induce morphologic damages in the hippocampus,
which is intimately connected to the HPA axis (Bremner et al.,
2000). Accordingly, the expression of BDNF, BDNF regulated
genes and TrkB receptors are decreased in post mortem hip-
pocampal tissues harvested from depressed human brains (Tripp
et al., 2012). Similar ﬁndings have also been reported for the
prefrontal cortex, another brain region essential for mood reg-
ulation. Moreover, BDNF protein levels are reduced in the serum
of depressed patients (Castren et al., 2007; Castren and Ranta-
maki, 2010; Thompson Ray et al., 2011). It is important to note
that, post mortem hippocampal BDNF levels and serum concen-
trations were normalized in depressed patients successfully treated
with antidepressants, suggesting that the therapeutic effect of these
compounds is related to BDNF activity (Duman and Monteggia,
2006).
However, human studies are only correlative and a clear causal
association between impairment of BDNF brain activity and
depression has not been yet demonstrated in human patients.
Thus, preclinical studies have attempted to validate this theory.
Converging studies have shown that stress (both physical and
psychological) is able to lower BDNF expression levels in rat hip-
pocampus (Duman and Monteggia, 2006) and that direct BDNF
infusion in this area reduces stress-induced depressive-like behav-
iors (Hoshaw et al., 2005; Hu and Russek, 2008). Viral-mediated
deletion of BDNForTrkB genes in theVTA resulted in a signiﬁcant
antidepressant-like response as well. However, results discrep-
ancy made complicated the interpretation. For instance, mice
exposed to a chronic social defeat exhibited increased depressive-
like behaviors and increased BDNF protein levels in the nucleus
accumbens and amygdala (Berton andNestler, 2006; Yu andChen,
2011). Therefore, the current hypothesis, suggesting a strong link
between low BDNF brain levels and depression, appears to be too
simplistic and has to be reconsidered. One possible explication
is that BDNF gene expression may be down regulated in some
brain structures (like hippocampus and prefrontal cortex) and up
regulated in others.
Interestingly, compelling evidence demonstrated that BDNF
has a direct role in the regulation of homeostatic and hedonic
eating as well (Lyons et al., 1999; Kernie et al., 2000; Rios et al.,
2001; Xu et al., 2003). With regards to the homeostatic regulation,
early studies showed that ICV injection of BDNF in rats led to a
reduction of body weight, suggesting that BDNF could take part in
the central control of feeding behavior (Lapchak and Hefti, 1992;
Pelleymounter et al., 1995b). More recently, BDNF deﬁciency has
been associated with increased weight in mice (Noble et al., 2011;
Schwartz and Mobbs, 2012), while leptin injected in the ven-
tromedian hypothalamus (VMH) would exert an anorexigenic
effect activating the expression of BDNF (Komori et al., 2006).
The relevance of BDNF in energy balance was also conﬁrmed in
mutant mice. Heterozygous BDNF +/- mice show hyperphagia,
body weight gain, insulin resistance, dyslipidemia, and hyper-
glycemia. In addition, these mice were more sensitive to negative
effects of a high fat diet (Lyons et al., 1999; Kernie et al., 2000).
Similarly, mice expressing only about 25% of TrkB receptors dis-
play excessive feeding (Xu et al., 2003). Inversely, BDNF infusion
in the VMH of adult wild-type mice resulted in decreased food
intake and body weight (Wang et al., 2007). Consistent with a
role in homeostatic mechanisms, levels of expression of BDNF
and trkB in hypothalamus and hindbrain regions are inﬂuenced
by the energy status (Xu et al., 2003; Bariohay et al., 2005; Tran
et al., 2006; Unger et al., 2007). Preclinical studies also support a
role for BDNF in regulating hedonic feeding by modulating the
mesolimbic dopamine (Seroogy et al., 1994; Numan and Seroogy,
1999; Cordeira et al., 2010). Meanwhile, only a limited num-
ber of human studies managed to correlate BDNF expression
to obesity. Human BDNF haploinsufﬁciency was linked to ele-
vated food intake and obesity (Gray et al., 2006; Han et al., 2008).
Recent evidence also associated a functional polymorphism of
the Bdnf gene, Bdnf Val66met which impedes a correct secre-
tion and signaling of BDNF, with obesity predisposition (Beckers
et al., 2008; Skledar et al., 2012), and the missense mutation in
the TrkB gene, which prevents TrkB function, has been identiﬁed
in patients exhibiting overweight and severe obesity (Yeo et al.,
2004).
Interestingly, adhering to a balanced diet was shown to inﬂu-
ence neurogenic factors, and potentially alleviates signs of depres-
sion and obesity. Depressed patients following a Mediterranean
diet exhibited signs of remission concomitant to increased plasma
BDNF concentrations (Sanchez-Villegas et al., 2011; Sanchez-
Villegas and Martinez-Gonzalez, 2013). Meanwhile, overweight
and obese patients exposed to a 3-months calorie restricted diet
displayed increased levels of serum BDNF (Araya et al., 2008). On
the other hand, high fat meals were shown to decrease plasma
BDNFof almost 30% inhealthy patients (Karczewska-Kupczewska
et al., 2012). These observations have been conﬁrmed in preclin-
ical studies since BDNF level decreased in rats maintained on
a high carbohydrate diet (Maioli et al., 2012), and high fat diet
(Yamada-Goto et al., 2012), whereas caloric restriction increases
BDNF expression (Lee et al., 2002; Duan et al., 2003).
Further investigation has revealed that ω-3 PUFA may play a
role in neurogenesis. In animals,ω-3 PUFA supplementation pro-
vided protection against reduced plasticity and normalized BDNF
after traumatic brain injury (Wu et al., 2004), whereas diets deﬁ-
cient in ω-3 PUFA lowered BDNF brain levels (Rao et al., 2007;
Bhatia et al., 2011).
Taken together these data suggest that BDNF pathway may be a
relevant biological substrate underlying the pathogenesis of both
mood and eating disorders. However, considering the emerging
data on complexity of BDNF pathway, further ﬁndings are needed
to better understand whether BDNF is a real causal factor for the
depression-obesity association.
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CONCLUDING REMARKS
Obesity and depression represent a global health burden, and the
diagnostic is even more severe for those individuals suffering from
both diseases. The increasing prevalence of depression-obesity
co-morbidity strongly suggests that these disorders may share a
common pathogenesis.
Earlier and current ﬁndings clearly demonstrated a link
between the two pathologies but the nature of their association
is still to be fully understood. The complexity comes from the
fact that both obesity and depression are heterogenic diseases,
inﬂuenced by multiple environmental and genetic factors. Clinical
works have identiﬁed environmental factors that seem to facilitate
the development of obesity as well as that of depression. In par-
ticular, factors like stress and diet quality have a strong impact
on both pathologies and may constitute key mediators for the
obesity-depression association. Other risk factors, reduced physi-
cal activity, sleep impairments and altered circadian rhythms, are
also considered relevant but most likely as factors worsening the
acquired pathologies rather that factors inﬂuencing the emergence
of the diseases.
Collectively, clinical studies reviewed in this article suggest that
obesity and depression are closely related but may not be glob-
ally interconnected. Indeed, only subgroups of obese patients are
at higher risk for developing depression, and vice versa. Accu-
mulating evidence emphasizes that mainly patients with BEDs
and those with abdominal fat deposition and metabolic syn-
drome are at higher risk for depression. The identiﬁcation of
these two subgroups of obese individuals is promising for discover-
ing the biological mechanisms underlying the obesity-depression
association.
In the last years, clinical and preclinical studies have also found
that leptin may represent a biological substrate underlying the
pathogenesis of both obesity and depression. Circulating leptin
increases proportionally with body mass and is signiﬁcantly ele-
vated in obese patient in comparison with non-obese individuals.
However, persistent high levels of the hormone alter leptin signal-
ing in the brain, most likely due to leptin resistance compensatory
mechanisms. This deﬁcit is believed to trigger a maladaptive func-
tioning of the brain homeostatic system, ultimately leading to
obesity. Since converging evidence suggests that impaired leptin
signaling may affect mood regulation and food reward percep-
tion in humans, impaired leptin signaling cascades may represent
a biological mechanism binding obesity and depression, in par-
ticular when obesity is paired with compulsive overeating. This
assumption opens novel perspectives for the development of ther-
apeutic medications able to correct clinical signs of obesity and
depression.
Substantial fat deposition is known to stimulate inﬂamma-
tory processes, which in turn, promote peripheral inﬂamma-
tory cytokines release. These molecules enter the brain, not
only affecting the hypothalamic control of food intake but
also impacting other brain functions that are pivotal for mood
regulation. Consistent with this hypothesis, someﬁndings demon-
strated that high levels of inﬂammatory cytokines might inter-
fere with serotonin and dopamine neurotransmission, and with
HPA axis as well. Although they need to be conﬁrmed, these
ﬁndings suggest that the inﬂammatory hypothesis of eating
and mood disorders should get a larger attention in the near
future.
The stress response is known to alter the HPA axis functioning
and to trigger depressive symptoms and eating disorders. Deci-
phering the contribution of CRF signaling in these twopathologies
remains quite difﬁcult though. Indeed,CRFhas opposite effects on
depressive symptoms depending onwhich brain receptors are acti-
vated, butCRFbinding toCRF receptor 1 seems to exacerbate signs
of depression while increasing food intake. The development of
CRF receptor 1 antagonists may represent another relevant strat-
egy for improving mood and eating disorders. Inhibitors of GCs
are currently used for treating the Cushing’s syndrome and some
cancers of the adrenal gland, but no medications are available to
date for treating depression or obesity.
The neurothrophic hypothesis of depression has received par-
ticular attention, but the current knowledge remains elusive and
recent evidence, rather than establishing a clear-cut role for
BDNF to causally link depression to obesity, mainly claim for
further studies before delineating any mechanism underlying the
association obesity-depression.
In conclusion, compelling evidence shows that obesity and
depression are two overlapping pathologies. However, the causal
link between eating andmooddisorders needs to be clariﬁed. Most
likely, different mechanisms may contribute to the worsening of
each disease, and a global cure does not sound realistic. Instead,
a better understanding of the molecular and cellular adaptations
occurring in subgroups of obese (or depressed) patients identiﬁed
as highly vulnerable to develop comorbidities should be a clini-
cal priority. Meanwhile, improving animal models of eating and
mood disorders is critical for unraveling the underpinnings of the
obesity-depression association.
However, given the deleterious impact of stress and junk
food consumption on the onset and progression of these two
pathologies, themost effective prevention program remains public
campaign defending the adherence to healthy balanced diets and
promoting effective programs of stress management.
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